Diabetic Therapy
GLYJENTA DP
Linagliptin 5mg + Dapagliflozin 10mg
Dosage Form
Tablets
Packing
10*10 ALU-ALU
MRP
₹1799
Prescribed By
Diabetologist, Endocrinologist, General Physician, Internal Medicine, Family Medicine
Quick Facts
Form
Tablets
Pack
10×10 ALU-ALU
MRP
₹1799
Prescribed By
Diabetologist, Endocrinologist, General Physician
Key Benefits
01
Two modern glucose-lowering mechanisms from different drug classes.
02
Both agents have renal and cardiovascular safety data.
03
No Metformin — suitable for patients where Metformin is not tolerated.
04
Convenient combination tablet.
Mechanism of Action
Linagliptin increases insulin secretion via DPP-4 inhibition. Dapagliflozin causes glucose excretion via the kidneys (SGLT-2 inhibition). Two modern glucose-lowering mechanisms with complementary organ protection profiles.
Indications
Type 2 diabetes requiring dual modern antidiabetic therapy with renal or cardiac protection.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why GLYJENTA DP?
GLYJENTA DP is a modern, Metformin-free combination of two advanced antidiabetic agents — ideal for patients who cannot take Metformin but need effective, organ-protective glucose control.
